Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221

Cancers - Switzerland
doi 10.3390/cancers12010027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

In Vitro and in Vivo Activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor Against Endometrial Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Erratum To: In Vitro and in Vivo Activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor Against Endometrial Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Overexpression of miR‑221 and miR‑222 in the Cancer Stroma Is Associated With Malignant Potential in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Nucleic Acid-Based Approaches for Detection of Viral Hepatitis

Jundishapur Journal of Microbiology
Infectious DiseasesMicrobiology
2014English

Erratum To: Evaluation of Locked Nucleic Acids for Signal Enhancement of Oligonucleotide Probes for Microalgae Immobilised on Solid Surfaces

Journal of Applied Phycology
Plant ScienceAquatic Science
2010English

Gefitinib for Non-Small-Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Gene Mutations Screened by Peptide Nucleic Acid-Locked Nucleic Acid PCR Clamp

British Journal of Cancer
Cancer ResearchOncology
2006English

Splice-Switching Efficiency and Specificity for Oligonucleotides With Locked Nucleic Acid Monomers

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2008English

Expression and Prognostic Significance of miR-375 and miR-221 in Liver Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Selective Tissue Targeting of Synthetic Nucleic Acid Drugs

Journal of Clinical Investigation
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy